AISNMA, the sole nodal agency for syringe manufacturers in India wrote to the Centre offering an additional capacity of over 350 million syringes per month in order to meet the entire demand for mass COVID-19 vaccination through domestic production.
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.